Emax Health -- CANCER RESEARCH UK-funded scientists have shown that an early chemotherapy drug invented in the 1940s has the potential to work against a genetic fault called HNPCC which is linked to bowel and other cancers. The results are published in EMBO Molecular Medicine.
